advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (125)
Showing records 1 to 25
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation60542 Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital
Teuchner B
Medicine 2015; 94: e583
60640 Genomic and post-genomic effects of anti-glaucoma drugs preservatives in trabecular meshwork
Izzotti A
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2015; 772: 1-9
60294 Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure
Lambert WS
Translational vision science & technology 2015; 4: 1
60624 From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability
Rossi GC
Expert Opinion on Drug Safety 2015; 14: 619-623
60097 Stability of Latanoprost in Generic Formulations Using Controlled Degradation and Patient Usage Simulation Studies
Velpandian T
Current Eye Research 2015; 40: 561-571
60781 Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study
Saade CE
Canadian Journal of Ophthalmology 2015; 50: 132-136
60477 Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues
Kocabeyoglu S
Indian Journal of Ophthalmology 2015; 63: 15-19
60628 Impact of supply problems of preservative-free glaucoma medications on patients and hospital staff
Shah S
Ophthalmic and Physiological Optics 2015; 35: 236-241
60505 Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency
Loma P
Experimental Eye Research 2015; 134: 141-147
60168 Original preparations versus generics--latanoprost: how similar is different?
Leitritz MA
Ophthalmologe 2015; 112: 127-139
60259 A Survey on the Preference of Sustained Glaucoma Drug Delivery Systems by Singaporean Chinese Patients: A Comparison Between Subconjunctival, Intracameral, and Punctal Plug Routes
Chan HH
Journal of Glaucoma 2015; 24: 485-492
60589 Dry eye specific quality of life in veterans using glaucoma drops
Camp A
Contact Lens and Anterior Eye 2015; 38: 220-225
60150 Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells
Smedowski A
Journal of biochemical and pharmacological research 2014; 2: 175-184
60630 Usability of prostaglandin monotherapy eye droppers
Drew T
British Journal of Ophthalmology 2015; 99: 1251-1254
60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Kanamoto T
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164
60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Nagai N
Experimental Eye Research 2015; 132: 115-123
60575 Nanotherapies for the treatment of ocular diseases
Reimondez-Troitiño S
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 279-293
60578 Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives
Ramli N
Optometry and Vision Science 2015; 92: e222-e226
60084 A National Survey of Glaucoma Specialists on the Preoperative (Trabeculectomy) Management of the Ocular Surface
Tailor R
Seminars in Ophthalmology 2014; 0: 1-7
60161 Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study
Bae HW
Journal of ginseng research 2015; 39: 7-13
60323 Sustained drug release by contact lenses for glaucoma treatment-a review
Carvalho IM
Journal of Controlled Release 2015; 202: 76-82
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Pfeiffer N
Advances in Therapy 2014; 31: 1228-1246
60330 Progression of drug delivery system for glaucoma
Xu Y
Chinese Journal of Ophthalmology 2014; 50: 946-951
60612 Evaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma
Junqueira DM
Clinical Ophthalmology 2015; 9: 367-371
60168 Original preparations versus generics--latanoprost: how similar is different?
Lipp HP
Ophthalmologe 2015; 112: 127-139
